Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial

H Thiele, T Kurz, HJ Feistritzer, G Stachel… - European Heart …, 2020 - academic.oup.com
Aims Transcatheter aortic valve implantation (TAVI) has emerged as established treatment
option in patients with symptomatic aortic stenosis. Technical developments in valve design …

Prosthesis tailoring for patients undergoing transcatheter aortic valve implantation

PP Leone, A Scotti, EC Ho, M Assafin… - Journal of clinical …, 2023 - mdpi.com
Transcatheter aortic valve implantation (TAVI) has risen over the past 20 years as a safe and
effective alternative to surgical aortic valve replacement for treatment of severe aortic …

Imaging for tricuspid valve repair and replacement

E Agricola, L Asmarats, F Maisano, JL Cavalcante… - Cardiovascular …, 2021 - jacc.org
Primary or secondary tricuspid regurgitation (TR) represents an important health care
burden and challenge which has often been neglected or undertreated in the past. The …

Impact of Sapien 3 balloon-expandable versus Evolut R self-expandable transcatheter aortic valve implantation in patients with aortic stenosis: data from a nationwide …

P Deharo, A Bisson, J Herbert, T Lacour… - Circulation, 2020 - Am Heart Assoc
Background: Two competing transcatheter aortic valve replacement (TAVR) technologies
are currently available. Head-to-head comparisons of the relative performances of these 2 …

The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes

H Möllmann, DM Holzhey, M Hilker… - Clinical Research in …, 2021 - Springer
Background Transcatheter aortic valve implantation (TAVI) has become standard treatment
for elderly patients with symptomatic severe aortic valve stenosis. The ACURATE neo AS …

[HTML][HTML] Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2

A Scotti, M Pagnesi, WK Kim, U Schäfer… - …, 2022 - ncbi.nlm.nih.gov
Background Transcatheter aortic valve replacement (TAVR) with the ACURATE neo device
has been associated with a non-negligible incidence of paravalvular aortic regurgitation …

Transcatheter self-expandable valve implantation for aortic stenosis in small aortic annuli: the TAVI-SMALL registry

D Regazzoli, M Chiarito, F Cannata, M Pagnesi… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to evaluate and compare the outcomes of transcatheter
self-expandable prostheses in patients with small annuli. Background Transcatheter aortic …

Incidence, predictors, and prognostic impact of new permanent pacemaker implantation after TAVR with self-expanding valves

M Pagnesi, WK Kim, S Baggio, A Scotti… - Cardiovascular …, 2023 - jacc.org
Objectives The authors sought to evaluate the incidence, predictors, and outcomes of new
permanent pacemaker implantation (PPI) after transcatheter aortic valve replacement …

Transcatheter aortic valve replacement with the latest-iteration self-expanding or balloon-expandable valves: the multicenter OPERA-TAVI registry

G Costa, F Saia, T Pilgrim, M Abdel-Wahab… - Cardiovascular …, 2022 - jacc.org
Background The latest iterations of devices for transcatheter aortic valve replacement
(TAVR) have brought refinements to further improve patient outcomes. Objectives This study …

Considerations for optimal device selection in transcatheter aortic valve replacement: a review

BE Claessen, GHL Tang, AS Kini, SK Sharma - JAMA cardiology, 2021 - jamanetwork.com
Importance Aortic valve stenosis (AS) is the most common manifestation of acquired valvular
heart disease in developed countries. Several large-scale randomized clinical trials …